Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONOCEPT: MMF Monotherapy in Liver Transplant
NCT00456235Phase 4Completed
- Sponsor
- CHU de Limoges
- Start
- Sep 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in Liver transplant rejection (2 arms), sponsored by CHU de Limoges. Primary endpoint: Incidence of biopsy proven acute rejection treated at 6 months. Started Sep 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00456235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456235.